Genetically engineered mouse models of mammary intraepithelial neoplasia

Journal of Mammary Gland Biology and Neoplasia

Volumn 5, Issue 4, 2000, Pages 421-437

  Cardiff, Robert D ^a   Moghanaki, Drew ^b,c   Jensen, Roy A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Association; Atypia; Dysplasia; Focality

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DYSPLASIA; BREAST EPITHELIUM; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FOCAL EPITHELIUM HYPERPLASIA; GENETIC ASSOCIATION; GENETIC ENGINEERING; MALIGNANT TRANSFORMATION; MAMMARY GLAND; MOUSE; NONHUMAN; REVIEW; TISSUE TRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0034458540     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009534129331     Document Type: Review

References (121)

1. Transgenic mouse models of breast cancer
2. Mammary morphogenesis and oncogenes
3. Transgenic mouse models of mammary tumorigenesis
4. Understanding transgenes in mammary tumorigenesis: Five rules
5. Comparative pathology of mammary tumorigenesis in transgenic mice
6. The histopathology of transgenes and knockouts in the mammary gland
7. The comparative pathology of human and mouse mammary glands
8. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting
9. Transgenic models of breast cancer metastasis
10. Preneoplasia in mammary tumorigenesis
11. The mammary gland: A unique organ for the study of development and tumorigenesis
12. Expression of activated oncogenes in the murine mammary gland: Transgenic models for human breast cancer
13. Transgenic animals and transgenic mammary glands
14. Transgenic mice and host cell mutants resistant to transformation as model systems for identifying multiple components in oncogenesis
15. Mammary tumorigenesis and metastasis in transgenic mice
16. Protoneoplasia: The molecular biology of murine mammary hyperplasia
17. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations
18. Risk factors for breast cancer in women with proliferative breast disease
19. Breast cancer risk of lobular-based hyperplasia after biopsy: "Ductal" pattern lesions
20. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
21. Premalignant and malignant disease of the breast: The roles of the pathologist
22. Ductal carcinoma in situ: Introduction of the concept of ductal intraepithelial neoplasia
23. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast
24. A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit
25. Correlative studies of the histological and radiographic appearance of the breast parenchyma
26. Preneoplastic lesions in the human breast
27. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice
28. Mammary neoplasia in mice
29. Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain
30. Biology of breast preneoplasia
31. The preneoplastic state in mouse mammary tumorigenesis
32. Nononeoplastic and neoplastic lesions of the mammary gland
33. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
34. Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice
35. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
36. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
37. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
38. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma
39. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage
40. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice
41. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells
42. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis
43. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice
44. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice
45. Amplification of the neu/erbB-2 oncogene in a novel mouse model of mammary tumorigenesis
46. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumor formation
47. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
48. FVB/N: An inbred mouse strain preferable for transgenic analyses
49. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression
50. Spontaneous lesions in aging FVB/N mice
51. Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras protooncogene
52. Binary system for regulating transgene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements
53. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice
54. Transgenic oncogenic mice: Tumor phenotype predicts genotype
55. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice
56. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin
57. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
58. Activated neu induces rapid tumor progression
59. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
60. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
61. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV- c-erbB-2 and MMTV-TGFalpha transgenic rats
62. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis
63. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein
64. c-myc protein distribution: Mammary adenocarcinomas of MTV/MYC transgenic mice
65. Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
66. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice
67. Differential expression of the neu transgene in murine mammary tissues
68. Active signaling by neu in transgenic mice
69. Synergistic interaction of the neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice
70. The C2(1)/SV40-Tantigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
71. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland
72. Ha-ras oncogene expression directed by a milk protein gene promoter: Tissue specificity, hormonal regulation, and tumor induction in transgenic mice
73. Subgross pathology of the human breast: Method and initial observations
74. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions
75. Persistent and atypical lobules in the human breast may be precancerous
76. The prevalence of the precancerous lesions in breasts contralateral to clinical cancer. A morphological comparison with breasts containing a benign lump
77. On the origin and progression of ductal carcinoma in the human breast
78. Development of human breast cancer
79. Apocrine cystic metaplasia: Subgroups pathology and prevalence in cancer - Associated versus random autopsy breasts
80. Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse
81. Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer
82. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice
83. The int-2 gene product acts as an epithelial growth factor in transgenic mice
84. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors
85. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants
86. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia
87. Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice
88. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice
89. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis
90. Preneoplastic mammary tumor markers: Cripto and amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice
91. Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk
92. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas
93. Dominant-negative interference of the transforming growth beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice
94. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice
95. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
96. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
97. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors
98. Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors
99. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene
100. Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice
101. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands
102. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis
103. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology
104. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha
105. Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: Distinct effects in various tissues
106. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
107. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene
108. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene
109. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice
110. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
111. Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development
112. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription
113. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis
114. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
115. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E
116. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene
117. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene
118. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities
119. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
120. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
121. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice